click below
click below
Normal Size Small Size show me how
PTA Pulm Pharm
Pharmacology for Pulmonary Disease Management
Term | Definition |
---|---|
Antihistamine Agents | Block affects of histamine; decreased nasal drainage, mucosal irritation, symptoms of cold and sinus, sinusitis, conjunctivitis and allergies |
Anti-Inflammatory Agents | inhaled corticosteroids, leukotriene modifiers, and mast cell stabilizers; help prevent inflammatory-mediated bronchoconstriction; inhibits inflammatory cells, release of inflammatory mediators and reverses capillary permeability; Reduces airway edema |
Bronchodilator Agents | relieve bronchospasm by stimulating receptors that cause bronchial smooth mm relaxation or blocking the receptors that triggerbronchoconstriction |
Expectorant Agents | increase respiratory secretion and loosen mucus; Reduces viscosity of secretions and increase sputum volume |
Mucolytic Agents | Decrease viscosity of mucus by altering composition and consistency; easier expectorant; using a nebulizer |